Design and Production of a Novel Polypeptide with Immunogenic Potentials for Immunoassay of Brucella Melitensis

Sahel Hossein Sharghi, Parviz Pakzad Pakzad, Mojgan Bandehpour

44

Abstract

Brucellosis is one of the most common diseases in humans and it has a worldwide spread. The design and production of newly synthesized proteins can be served as a goal for the rapid and accurate detection of brucellosis. To this aim, finding the antigenic epitopes is the first step to design a diagnostic method. In this study, the epitope mapping procedure was carried out by IEDB analysis resource using Flagellin and Porin amino acid sequences. The selected sequences were linked by GS linkers and cloned into pET26b vector. After confirmation of the expressed recombinant polypeptide by western blotting, it was immunologically analyzed by gel diffusion assay. The SDS PAGE and western blot analysis confirmed the 27 KDa polypeptide production and observing an arc in gel diffusion test demonstrated the precipitation of serum antibodies and the presence of specific antigen complexes. The results showed that the recombinant polypeptide produced in E. coli BL21, could interact with antibodies present in Brucella immunized sheep serum.


HIGHLIGHTS
•Prediction of antigenic epitopes for Brucella membrane proteins.
•Production of designed polypeptide in E. coli BL21 (DE3).
•Interaction of produced polypeptide with Brucella specific antibodies.

Keywords

Brucellosis; Epitopes; Recombinant

Full Text:

PDF

References

Bhattacharjee, A. K., Van De Verg, L., Izadjoo, M. J., Yuan, L., Hadfield, T. L., Zollinger, W. D. and D. L. Hoover, (2002). "Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysaccharide as a noncovalent complex with Neisseria meningitidis group B outer membrane protein." Infection and Immunity, 70(7): 3324-3329.

Corbel, M. J. (2006). "Brucellosis in humans and animals." World Health Organization, Geneva, Switzerland, pp. 1-69.

Franco, M. P., Mulder, M., Gilman, R. H. and H. L. Smits, (2007). "Human brucellosis." The Lancet Infectious Diseases, 7(12): 775-786.

Guilloteau, L. A., Laroucau, K., Vizcaı́no, N., Jacques, I. and G. Dubray, (1999). "Immunogenicity of recombinant Escherichia coli expressing the omp31 gene of Brucella melitensis in BALB/c mice." Vaccine, 17(4): 353-361.

He, Y. (2012). "Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics." Frontiers in Cellular and Infection Microbiology, 2: 2.

Lord, V., M. Rolo and J. Cherwonogrodzky (1989). "Evaluation of humoral immunity to Brucella sp in cattle by use of an agar-gel immunodiffusion test containing a polysaccharide antigen." American Journal of Veterinary Research, 50(11): 1813-1816.

McDermott, J., D. Grace and J. Zinsstag (2013). "Economics of brucellosis impact and control in low-income countries." Revue Scientifique et Technique, 32(1): 249-261.

Moreno, E. and I. Moriyón, (2002). "Brucella melitensis: a nasty bug with hidden credentials for virulence." Proceedings of the National Academy of Sciences, 99(1): 1-3.

Olsen, S. C. and W. Stoffregen, (2005). "Essential role of vaccines in brucellosis control and eradication programs for livestock." Expert Review of Vaccines, 4(6): 915-928.

Pathak, P., Kumar, A. and D. Thavaselvam, (2017). "Evaluation of recombinant porin (rOmp2a) protein as a potential antigen candidate for serodiagnosis of Human Brucellosis." BMC Infectious Diseases, 17(1): 485.

Sankian, M., Yousefi, M., Pazouki, N. and A. Varasteh, (2007). "One-step purification of histidine-tagged profilin with high purity and yield by using metal precipitation." Biotechnology and Applied Biochemistry, 47(Pt 4): 185-189.

Schurig, G. G., Sriranganathan, N. and M. J. Corbel (2002). "Brucellosis vaccines: past, present and future." Veterinary Microbiology, 90(1): 479-496.

Seco-Mediavilla, P., Verger, J. M., Grayon, M., Cloeckaert, A., Marín, C. M., Zygmunt, M. S., Fernández-Lago, L. and N. Vizcaíno, (2003). "Epitope mapping of the Brucella melitensis BP26 immunogenic protein: usefulness for diagnosis of sheep brucellosis." Clinical and Diagnostic Laboratory Immunology, 10(4): 647-651.

Van De Verg, L. L., Hartman, A. B., Bhattacharjee, A. K., Tall, B. D., Yuan, L., Sasala, K., Hadfield, T. L., Zollinger, W. D., Hoover, D. L. and R. L. Warren, (1996). "Outer membrane protein of Neisseria meningitidis as a mucosal adjuvant for lipopolysaccharide of Brucella melitensis in mouse and guinea pig intranasal immunization models." Infection and Immunity, 64(12): 5263-5268.

Yin, D., Li, L., Song, X., Li, H., Wang, J., Ju, W., Qu, X., Song, D., Liu, Y. and X. Meng, (2016). "A novel multi-epitope recombined protein for diagnosis of human brucellosis." BMC Infectious Diseases, 16(1): 219.

Refbacks

  • There are currently no refbacks.